{"id":"https://openalex.org/W2396696358","doi":null,"title":"[Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].","display_name":"[Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2396696358","mag":"2396696358","pmid":"https://pubmed.ncbi.nlm.nih.gov/26652963"},"language":"cs","primary_location":{"id":"pmid:26652963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26652963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000359677","display_name":"Michaela \u0160nejdrlov\u00e1","orcid":"https://orcid.org/0000-0003-1087-9795","observed_orcids":["https://orcid.org/0000-0003-1087-9795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michaela \u0160nejdrlov\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017005943","display_name":"R \u010ce\u0161ka","orcid":"https://orcid.org/0000-0002-2541-5179","observed_orcids":["https://orcid.org/0000-0002-2541-5179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard \u010ce\u0161ka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003304093","display_name":"Denisa Jan\u00ed\u010dkov\u00e1 \u017d\u010farsk\u00e1","orcid":"https://orcid.org/0000-0002-8143-7276","observed_orcids":["https://orcid.org/0000-0002-8143-7276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denisa Jan\u00ed\u010dkov\u00e1-\u017d\u010f\u00e1rsk\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087488905","display_name":"Petr Hon\u011bk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petr Hon\u011bk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058266776","display_name":"Pavel Du\u0161ek","orcid":"https://orcid.org/0000-0003-4307-8206","observed_orcids":["https://orcid.org/0000-0003-4307-8206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pavel Du\u0161ek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037319451","display_name":"Tom\u00e1\u0161 Pavl\u00edk","orcid":"https://orcid.org/0000-0001-7166-032X","observed_orcids":["https://orcid.org/0000-0001-7166-032X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom\u00e1\u0161 Pavl\u00edk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051785805","display_name":"Milan Kvapil","orcid":"https://orcid.org/0000-0002-4020-9146","observed_orcids":["https://orcid.org/0000-0002-4020-9146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Milan Kvapil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"61","issue":"11 Suppl 3","first_page":"3S30","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5580999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5580999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.2883000075817108,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.10329999774694443,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9589999914169312},{"id":"https://openalex.org/keywords/diabetic-dyslipidemia","display_name":"diabetic dyslipidemia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.527999997138977},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.968999981880188},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9789999723434448},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7490000128746033},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.8220000267028809},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.6370000243186951},{"id":"https://openalex.org/keywords/czech-republic","display_name":"Czech Republic","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.865621030330658},{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.7488781213760376},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7087510824203491},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.6889239549636841},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6019219756126404},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5882443189620972},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5676023960113525},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.5189909338951111},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5171951055526733},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.42545977234840393},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4186205565929413},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.41800954937934875},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34602901339530945},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2821540832519531},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.25659888982772827}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007348","descriptor_name":"Insurance, Health","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018153","descriptor_name":"Czech Republic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:26652963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26652963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Journal Article"},{"id":"mag:2396696358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26652963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1520609538","https://openalex.org/W1972661406","https://openalex.org/W2019392263","https://openalex.org/W2019806913","https://openalex.org/W2031027166","https://openalex.org/W2031831221","https://openalex.org/W2072456819","https://openalex.org/W2097870088","https://openalex.org/W2164089346","https://openalex.org/W3021659692","https://openalex.org/W3171237122"],"related_works":["https://openalex.org/W2053290267","https://openalex.org/W2092787548","https://openalex.org/W169622189","https://openalex.org/W1984333620","https://openalex.org/W2081850710","https://openalex.org/W7220452571","https://openalex.org/W1969752275","https://openalex.org/W2157252972","https://openalex.org/W2096549869","https://openalex.org/W2520678979"],"abstract_inverted_index":{"Diabetes":[0],"mellitus":[1,8,74],"and":[2,41,51,101,131,159,186,210],"in":[3,63,142,189],"particular":[4],"type":[5],"2":[6],"diabetes":[7,73],"is":[9,25,147],"one":[10],"of":[11,17,32,38,49,85,94,103,108,112,134,140,172,184,199,206],"the":[12,36,64,83,95,106,124,135,145,196,200],"most":[13,117],"important":[14,27],"risk":[15,23],"factors":[16],"cardiovascular":[18,22],"disease.":[19],"To":[20],"influence":[21,31],"there":[24],"enormous":[26],"not":[28],"only":[29],"positive":[30,197],"glycemia,":[33],"but":[34,149,188],"also":[35],"treatment":[37],"diabetic":[39],"dyslipidemia":[40],"hypertension.":[42],"The":[43],"present":[44],"work":[45],"provides":[46],"an":[47,204],"analysis":[48],"lipid-lowering":[50,136,174],"antihypertensive":[52,113],"therapy":[53,175,208],"for":[54],"all":[55],"diabetics":[56,88,155,161],"registered":[57,75],"with":[58,72,76,144],"General":[59,77],"Health":[60,78],"Insurance":[61,79],"Company":[62,80],"period":[65],"2010-2013.":[66],"In":[67],"this":[68],"time":[69],"866,570":[70],"patients":[71,96,115],"were":[81,87,97,116],"treated,":[82],"majority":[84],"them":[86,104],"independent":[89],"on":[90,195],"insulin.":[91],"Approximately":[92],"half":[93,102],"observed":[98],"by":[99,105,120,157,163,182],"dialectologists":[100,158],"doctors":[107],"other":[109],"specialization.":[110],"Out":[111],"medi-cation,":[114],"often":[118],"treated":[119,156,162],"drugs":[121],"that":[122],"affect":[123],"renin-angiotensin":[125],"system,":[126],"as":[127,129],"well":[128],"beta-blockers":[130],"diuretics.":[132],"Prescription":[133],"therapy,":[137],"especially":[138],"prescription":[139],"statins,":[141],"accordance":[143],"guidelines,":[146],"increasing,":[148],"remains":[150],"insufficient":[151],"(at":[152],"2013":[153],"43.6%":[154],"51.3%":[160],"GP\u00b4s":[164],"didn\u00b4t":[165],"have":[166],"lipid":[167],"lowering":[168],"therapy).":[169],"Inadequate":[170],"use":[171],"combination":[173,183,207],"was":[176],"recorded":[177],"too,":[178],"still":[179],"represented":[180],"mainly":[181],"statin":[185,209],"fibrate,":[187],"coming":[190],"years":[191],"we":[192],"expect":[193],"(based":[194],"results":[198],"subanalysis":[201],"IMPROVE-IT":[202],"study),":[203],"increase":[205],"ezetimibe.":[211]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}